These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3231107)

  • 21. [Molecular basis for the pathogenicity of S. aureus alpha-toxins].
    Bhakdi S; Suttorp N; Seeger W; Füssle R; Tranum-Jensen J
    Immun Infekt; 1984 Nov; 12(6):279-85. PubMed ID: 6510944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification of staphylococcal exfoliative toxin by high pressure liquid chromatography.
    Sugai M; Inoue S; Hino T; Kuwabara M; Hong YM; Miyake Y; Suginaka H
    Zentralbl Bakteriol; 1990 May; 273(1):5-11. PubMed ID: 2363797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between the production of alpha-toxin and growth rate in Staphylococcus aureus.
    Totake K; Ichikawa Y
    Microbiol Immunol; 1983; 27(4):389-94. PubMed ID: 6888295
    [No Abstract]   [Full Text] [Related]  

  • 24. [Production of monoclonal antibodies to staphylococcal alpha-toxin using the technique of in vitro immunization].
    Beliaev NN; Zakir'ianova GK; Kostin GO; Tleulieva RT; Agashkin AO; Navasardiants DG; Ezepchuk IuV; Beklemishev AB
    Biull Eksp Biol Med; 1991 Jul; 112(7):73-6. PubMed ID: 1793865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Preparation and properties of the staphylococcal toxin causing the toxic shock syndrome].
    Fan'kovskaia MK; Ezepchuk IuV; Solov'eva MN; Shcheglovitova ON
    Mol Gen Mikrobiol Virusol; 1987 Jul; (7):23-7. PubMed ID: 3670320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydrophobic interaction chromatography of Staphylococcus aureus delta-toxin.
    Nolte FS; Kapral FA
    Infect Immun; 1981 Mar; 31(3):1094-8. PubMed ID: 7228397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystallization of the alpha-hemolysin heptamer solubilized in decyldimethyl- and decyldiethylphosphine oxide.
    Song L; Gouaux E
    Acta Crystallogr D Biol Crystallogr; 1998 Mar; 54(Pt 2):276-8. PubMed ID: 9761893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of antibodies to staphylococcal alpha and beta toxins and Staphylococcus aureus on the cytotoxicity for and adherence of the organism to bovine mammary epithelial cells.
    Cifrian E; Guidry AJ; O'Brien CN; Marquardi WW
    Am J Vet Res; 1996 Sep; 57(9):1308-11. PubMed ID: 8874724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Isolation and purification of biologically active substances from Staphylococcus aureus isolated from a skin disease. II. Isolation and purification of exfoliative toxin].
    Sugai M
    Hiroshima Daigaku Shigaku Zasshi; 1987 Dec; 19(2):402-8. PubMed ID: 3504874
    [No Abstract]   [Full Text] [Related]  

  • 30. Purification of two different toxins from Shigella.
    Okamoto K; Takeda Y; Miwatani T
    Jpn J Med Sci Biol; 1979 Apr; 32(2):92-5. PubMed ID: 541877
    [No Abstract]   [Full Text] [Related]  

  • 31. Preparation of toxic shock syndrome toxin-1.
    Blomster-Hautamaa DA; Schlievert PM
    Methods Enzymol; 1988; 165():37-43. PubMed ID: 3231114
    [No Abstract]   [Full Text] [Related]  

  • 32. Purification of Staphylococcus aureus beta-toxin: comparison of three isoelectric focusing methods.
    Gaskin DK; Bohach GA; Schlievert PM; Hovde CJ
    Protein Expr Purif; 1997 Feb; 9(1):76-82. PubMed ID: 9116505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Theta-toxin of Clostridium perfringens. I. Purification and some properties.
    Yamakawa Y; Ito A; Sato H
    Biochim Biophys Acta; 1977 Oct; 494(2):301-13. PubMed ID: 199270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of the patterns of extracellular proteins produced by the high alpha-toxin-secreting organism Staphylococcus aureus (Wood 46) during aerobic and anaerobic growth.
    Coleman G
    J Gen Microbiol; 1985 Feb; 131(2):405-8. PubMed ID: 3981133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the pathogenesis of staphylococcal infection. V. Purification and characterization of staphylococcal alpha hemolysin.
    GOSHI K; CLUFF LE; NORMAN PS
    Bull Johns Hopkins Hosp; 1963 Jan; 112():15-30. PubMed ID: 13949383
    [No Abstract]   [Full Text] [Related]  

  • 36. Purification of Escherichia coli alpha-hemolysin.
    Bohach GA; Cavalieri SJ; Snyder IS
    Methods Enzymol; 1988; 165():137-46, 399. PubMed ID: 3068483
    [No Abstract]   [Full Text] [Related]  

  • 37. Liquiritigenin prevents Staphylococcus aureus-mediated lung cell injury via inhibiting the production of α-hemolysin.
    Dai XH; Li HE; Lu CJ; Wang JF; Dong J; Wei JY; Zhang Y; Wang X; Tan W; Deng XM; Zhao SH; Zhang MJ
    J Asian Nat Prod Res; 2013; 15(4):390-9. PubMed ID: 23464667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of toxin production in a murine model of Staphylococcus aureus keratitis.
    Girgis DO; Sloop GD; Reed JM; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2064-70. PubMed ID: 15914624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The CAMP test performed by using Staphylococcus aureus sphingomyelinase (beta-haemolysin) and Clostridium perfringens lecithinase.
    Holth-Haug R; Olsvik O
    NIPH Ann; 1981 Dec; 4(2):43-8. PubMed ID: 6278370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expectations regarding vaccines and immune therapies directed against Staphylococcus aureus alpha-hemolysin.
    Kernodle DS
    J Infect Dis; 2011 Jun; 203(11):1692-3; author reply 1693-4. PubMed ID: 21593000
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.